Per‐Anders Jansson

6.1k citations
71 papers · 5.1k · 2 hit papers · h-index 32

Impact in

    • Diabetes Treatment and Management
    • Diabetes, Cardiovascular Risks, and Lipoproteins
    • Diabetes Management and Research
    • Adipokines, Inflammation, and Metabolic Diseases
    • Liver Disease Diagnosis and Treatment

Papers in

Per‐Anders Jansson

71 papers receiving 4.9k citations

Per‐Anders Jansson's Hit Papers

Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study 2018 · 317 citations
3170+13+26Years since publication100200300400500

Peers

Per‐Anders Jansson
Comparison fields: 5 of 116
  • Endocrinology, Diabetes and Metabolism 1.5k
  • Epidemiology 1.4k
  • Biochemistry 257
  • Physiology 836
  • Pharmaceutical Science 133
Replace Peter Lönnroth with:
Peter Lönnroth Sweden
Vincent Poitout Canada
P. Nowotny Austria
R. Paul Robertson United States
Adria Giacca Canada
James Edward Foley United States
Gareth Geoffrey Lavery United Kingdom
Luigi Gnudi United Kingdom
Cora Weigert Germany
Józef Drzewoski Poland
Per‐Anders Jansson relative to Peter Lönnroth Sweden Peter Lönnroth's profile →
Citations per field
00.5×1.5×2×2.4×
Peter Lönnroth · 1×
Citations per year

Countries citing papers authored by Per‐Anders Jansson

Since Specialization
Citations

This map shows the geographic impact of Per‐Anders Jansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per‐Anders Jansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per‐Anders Jansson more than expected).

Fields of papers citing papers by Per‐Anders Jansson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per‐Anders Jansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per‐Anders Jansson. The network helps show where Per‐Anders Jansson may publish in the future.

Co-authors

The 25 scholars most cited alongside Per‐Anders Jansson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Per‐Anders Jansson Line = papers co-authored together Per‐Anders Jansson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2004631
2
A microdialysis method allowing characterization of intercellular water space in humans
Hit paper breakdown →
1987552
3 2002377
4
Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
Hit paper breakdown →
2018317
5 2015236
6 2004199
7 1992171
8 2004143
9 2006135
10 1994134
11 2003133
12 2003116
13 2008115
14 1990111
15 1988105
16 2003102
17 2008101
18 201898
19 198995
20 200492

About Per‐Anders Jansson

Per‐Anders Jansson is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism, Physiology, Surgery and Immunology, having authored 71 papers that have together received 5.1k indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (31 papers), Adipose Tissue and Metabolism (15 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Pancreatic function and diabetes (10 papers), Diabetes Management and Research (5 papers), Physical Activity and Health (4 papers), Galectins and Cancer Biology (4 papers) and Cardiovascular and exercise physiology (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.5k citations), Epidemiology (1.4k citations), Biochemistry (257 citations), Physiology (836 citations) and Pharmaceutical Science (133 citations). Per‐Anders Jansson has collaborated with scholars based in Sweden, Germany and Finland. Frequent co-authors include Ulf Smith, Peter Lönnroth, Bo Åhrén, Mona Landin‐Olsson, David Holmes, Ann Hammarstedt, Maria K Eriksson Svensson, Jan W. Eriksson, Anja Schweizer and Madeléne Sandqvist. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetologia, Diabetes, American Journal of Physiology-Endocrinology and Metabolism and Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact